Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biomaterials Research|December 23, 2024
Osseointegration-Related Exosomes for Surface Functionalization of Titanium ImplantsBoqiong Li, Huanming Chen, Ruiqiang Hang
International Journal of Plasticity|July 6, 2026
Constitutive modelling of hydrolytic degradation and viscoplasticity in glassy polymers: An effective temperature approachZhouzhou Pan, Huanming Chen, Laurence Brassart
Journal of the Mechanical Behavior of Biomedical Materials|December 9, 2025
Hydrolytic degradation behaviour of electrospun poly(ɛ-caprolactone) filaments for biological tissue repairThales Zanetti Ferreira, Huanming Chen, Kaili Chen, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2006
Identification of novel, selective and potent Chk2 inhibitorsGary Larson, Shunqi Yan, Huanming Chen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 8, 2019
Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsyFan Zhang, Yani Liu, Feng Tang, et al.
Bioactive Materials|April 10, 2026
Immune-activating PTL/nanowire composite coating on Ti surface enables macrophage-driven bacterial clearance and osseointegrationRuiyue Hang, Huanming Chen, Liwei Yang, et al.
Materials Today. Bio|January 6, 2025
Construction and high-throughput screening of gradient nanowire coatings on titanium surface towards ameliorated osseointegrationRuiyue Hang, Yuyu Zhao, Huanming Chen, et al.
Gastro Hep Advances|August 12, 2024
Safety, Tolerability, and Pharmacokinetics of a Novel Human Hepatitis B Virus Capsid Assembly Modulator Canocapavir: A Randomized First-in-Human StudyXiuhong Jiang, Bo Hua, Gang Liu, et al.
Oncotarget|July 6, 2015
Therapeutic efficacy of combined BRAF and MEK inhibition in metastatic melanoma: a comprehensive network meta-analysis of randomized controlled trialsRuiqin Mai, Songxia Zhou, Weixiang Zhong, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2006
Discovery of 3-hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles as potent MEK1 inhibitorsChamakura V N S Varaprasad, Dinesh Barawkar, Hassan El Abdellaoui, et al.
Pageof 2